|
|
||||||||
The FASEB Journal, Vol 11, 93-100, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
Y Song, CW Chan, GM Brown, SF Pang and M Silverman
Department of Medicine, University of Toronto, Ontario, Canada.
The pineal hormone melatonin controls circadian behavior of a variety of organs in different species, including humans. However, the precise mechanism (or mechanisms) by which this occurs remains largely unknown. At the cellular level its effects are believed to be mediated via interaction with specific melatonin receptors (MR), which have previously been cloned from human brain (Mel1a) and retina (Mel1b). At the tissue level, MR have been investigated primarily through empirical definition of specific binding sites, but so far there has been little success in biochemical or molecular characterization of native MR. In the kidney, there is strong circumstantial evidence that melatonin affects diurnal variations in renal function, but relatively little is known about the overall glomerular vs. tubular contributions to these effects. The strategy behind the present study was to use a panel of peptide-specific antibodies to identify MR proteins in various tissues, and from a determination of the intrarenal distribution of MR, gain insight into the mechanism by which melatonin might regulate kidney function. We used two peptide-specific antibodies directed against different regions of Mel1a to identify MR. Our results show that the native Mel1a receptor is a 37 kilodalton (kDa) protein in human and rat brain. Further, immunofluorescent studies carried out in guinea pig kidney have revealed that anti-Mel1a antibody is also localized to the basolateral membrane (BLM) of the renal cortical epithelium, especially the early proximal tubule. Immunoblotting of purified BLM fractions from guinea pig renal cortex and small intestine using the two different peptide-specific antibodies reveals the presence of a single peptide-blockable band at 37 kDa. These same BLM fractions also demonstrate the presence of high-affinity 2-[125I]iodomelatonin (125I- MEL) binding sites, with the pharmacological specificity of binding expected of the Mel1a receptor subtype, inhibited by guanosine 5'-O-(3'- thiotriphosphate) (GTPgammaS) and pertussis toxin. We conclude that functional MR in guinea pig kidney and small intestine are of the Mel1a subtype, and are expressed as 37 kDa proteins localized to the BLM and coupled to a pertussis toxin-sensitive G-protein (Gi). This localization strongly suggests that the proximal tubule plays a significant role in mediating the renal action of melatonin.
This article has been cited by other articles:
![]() |
H. G. Richter, C. Torres-Farfan, J. Garcia-Sesnich, L. Abarzua-Catalan, M. G. Henriquez, M. Alvarez-Felmer, F. Gaete, G. E. Rehren, and M. Seron-Ferre Rhythmic Expression of Functional MT1 Melatonin Receptors in the Rat Adrenal Gland Endocrinology, March 1, 2008; 149(3): 995 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, S.-C. Lee, and X.-L. Yang Modulation by melatonin of glutamatergic synaptic transmission in the carp retina J. Physiol., December 15, 2005; 569(3): 857 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Beau, M.-T. Groyer-Picard, A. Desroches, E. Condamine, J. Leprince, J.-P. Tome, P. Dessen, H. Vaudry, and M. Misrahi The Basolateral Sorting Signals of the Thyrotropin and Luteinizing Hormone Receptors: An Unusual Family of Signals Sharing an Unusual Distal Intracellular Localization, but Unrelated in Their Structures Mol. Endocrinol., March 1, 2004; 18(3): 733 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shakil, A. N. E. Hoque, M. Husain, and D. D. Belsham Differential Regulation of Gonadotropin-Releasing Hormone Secretion and Gene Expression by Androgen: Membrane Versus Nuclear Receptor Activation Mol. Endocrinol., November 1, 2002; 16(11): 2592 - 2602. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Scher, E. Wankiewicz, G. M. Brown, and H. Fujieda MT1 Melatonin Receptor in the Human Retina: Expression and Localization Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roy, N. L. Angelini, H. Fujieda, G. M. Brown, and D. D. Belsham Cyclical Regulation of GnRH Gene Expression in GT1-7 GnRH-Secreting Neurons by Melatonin Endocrinology, November 1, 2001; 142(11): 4711 - 4720. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brydon, F. Roka, L. Petit, P. de Coppet, M. Tissot, P. Barrett, P. J. Morgan, C. Nanoff, A. D. Strosberg, and R. Jockers Dual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 Proteins Mol. Endocrinol., December 1, 1999; 13(12): 2025 - 2038. [Abstract] [Full Text] |
||||
![]() |
I. Beau, M.-T. Groyer-Picard, A. Le Bivic, B. Vannier, H. Loosfelt, E. Milgrom, and M. Misrahi The Basolateral Localization Signal of the Follicle-stimulating Hormone Receptor J. Biol. Chem., July 17, 1998; 273(29): 18610 - 18616. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Y. Chan, Y. Song, M. Ailenberg, M. Wheeler, S. F. Pang, G. M. Brown, and M. Silverman Studies of Melatonin Effects on Epithelia Using the Human Embryonic Kidney-293 (HEK-293) Cell Line Endocrinology, November 1, 1997; 138(11): 4732 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gilad, H. Matzkin, and N. Zisapel Inactivation of Melatonin Receptors by Protein Kinase C in Human Prostate Epithelial Cells Endocrinology, October 1, 1997; 138(10): 4255 - 4261. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |